Table 1

Case–control studies on LMP1 expression and NPC metastasis

Publication yearFirst authorStudyTotalLMP1+LMP1−
Case noLMP1+ (%)Met (%)Case noMet caseMet (%)Case noMet caseMet (%)
1995Hu LFEur J Cancer7466.2258.11493673.4725728.00
2000Horikawa TCancer3860.5378.95232191.3015960.00
2001Chen CLHum Pathol16341.7212.2768913.24951111.58
2004Jeon YKHead Neck5961.0279.66363083.33231773.91
2007Jang WZChinese J Otorhinolaryngol–Skull Base Surg4072.577.5292586.2111654.55
2007Song YCJ TianJin Medical University5050.068.0252184.00251352.00
2007Li JCancer Biol Ther5642.8680.36241770.83322887.50
2008Tsuji AClin Cancer Res4233.3378.571414100.00281967.86
2008Ou XCancer Res Prev Treatment5667.8642.86381847.3718633.33
2008Fendri AOral Oncol4493.1995.464141100.003133.33
2009Bai WLin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi5366.0471.70352571.43181372.22
2010Liu QAPMIS4348.8469.77211257.14221881.82
Total case no/combined rate71856.1358.0840326966.7531514846.98
  • Met, metastasis; NPC, nasopharyngeal carcinoma.